MOESM4 of Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
收藏Figshare2023-06-01 更新2026-04-08 收录
下载链接：
https://springernature.figshare.com/articles/dataset/MOESM4_of_Baseline_antibody_profiles_predict_toxicity_in_melanoma_patients_treated_with_immune_checkpoint_inhibitors/6072557/1
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 4: Table S3. Sample details. Severity and site of toxicity (gastrointestinal (GI), endocrine, skin and/or other) and treatment termination status for baseline sera samples from anti-CTLA-4 (n = 39), anti-PD-1 (n = 28), and combination (n = 11) melanoma patients. Two anti-CTLA-4 patients were sampled twice (11-311, in 2011 and 2013; and 12-071, in 2012 and 2013), and one anti-PD-1 patient was sampled twice (13-185, in 2015 and 2016).
提供机构：
Moran, Una; Dawood, Zarmeena; Hu, Shaohui; Wilson, Melissa; Zhong, Hua; Kirchhoff, Tomas; Pavlick, Anna; Osman, Iman; Simpson, Danny; Giles, Keith; Gowen, Michael; Tchack, Jeremy; Zhou, Hua; Krogsgaard, Michelle
创建时间：
2018-04-02
